NATCO Pharma enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
14,195————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
777777441514437
0.00.05.3——
706706273363165
14,124————
−70.7−70.7−168−151−272
₹789.05————
9,9289,9287,8856,2165,039
7.1%7.1%3.5%5.8%3.3%
0.05×————
4.05×————
13.43×————
16.50×————
10.26×————
Reference items — trailing FY values
3,4854,0784,4303,9992,707
1,0521,4372,1961,751936
8561,2301,9611,565772
—1,7681,6971,212849
1,3771,3771,185853644
—1,3741,182850641
—391512359206
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NATCOPHARM₹793.00

NATCO Pharma Ltd.

· Pharma & Health
₹ CrorePeersDRREDDYZYDUSLIFESUNPHARMALALPATHLABNEULANDLABNHSAILIFECOHANCEMcap ₹14,195 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————14,194.7
- Cash, Equiv & ST Investments436.9513.9440.8777.1777.1
+ Minority Interest——5.30.00.0
+ Total Debt165.0363.2273.1706.4706.4
Enterprise Value————14,124.0
Net Debt (memo)-271.9-150.7-167.7-70.7-70.7
EV per Share————789.05
Total Capital5,038.86,216.37,885.49,927.59,927.5
Total Debt/Total Capital3.275.843.467.127.12
Total Debt/EV————0.05
EV/Sales————4.05
EV/EBITDA————13.43
EV/EBIT————16.50
EV/Free Cash Flow————10.26
Reference Items — Trailing FY Values
Sales2,707.13,998.84,429.54,078.33,484.6
EBITDA935.61,751.42,196.01,436.51,052.0
EBIT771.81,564.61,960.81,229.9855.9
Operating Cash Flow849.11,211.61,696.81,768.3—
Free Cash Flow643.5852.91,185.21,377.21,377.2
FCFF (free cash flow to the firm)641.1849.81,182.11,374.3—
Capital Expenditure205.6358.7511.6391.1—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.